MRC1 and cancer: Our study revealed that the evaluation of DNA MMR protein expression may be useful in predicting NMIBC cases that will respond well to BCG therapy and a better antitumour activity of BCG in NMIBC cases with decreased DNA MMR gene expression may be related to the cancer neoantigens caused by tumour gene mutations accumulating as a result of defective DNA repair.